Daunorubicin Market

Daunorubicin is mainly used for acute lymphocytic or myelogenous leukemia resistant to common anti-tumor drugs, but the remission period is short, so it needs to be combined with other drugs.It is orange-red acicular crystal, easily soluble in water.Its aqueous solution is quite stable and can be kept at 0? or 37? for 3 weeks without changing its activity.The effect is the same as adriamycin, embedded DNA, can inhibit the synthesis of RNA and DNA, the effect on RNA is particularly obvious, selective effect on purine nucleoside.

Daunorubicin Market contains market size and forecasts of Daunorubicin in global, including the following market information:

Global Daunorubicin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Daunorubicin Market Sales, 2017-2022, 2023-2028, (Litre)

Global top five Daunorubicin companies in 2021 (%)

The global Daunorubicin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intravenous Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Daunorubicin include Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, Gilead Sciences, Bedford Pharmaceuticals, United Biotech, Mercian Corporation, Pharmacia and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Daunorubicin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Daunorubicin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Litre)

Global Daunorubicin Market Segment Percentages, by Type, 2021 (%)

Intravenous

Drip

Global Daunorubicin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Litre)

Global Daunorubicin Market Segment Percentages, by Application, 2021 (%)

Acute Granulocyte

Acute Lymphocyte Leukemia

Global Daunorubicin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Litre)

Global Daunorubicin Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Daunorubicin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Daunorubicin revenues share in global market, 2021 (%)

Key companies Daunorubicin sales in global market, 2017-2022 (Estimated), (Litre)

Key companies Daunorubicin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Sanofi

Halison Pharmaceuiticals

Hikma Pharmaceuticals

Gilead Sciences

Bedford Pharmaceuticals

United Biotech

Mercian Corporation

Pharmacia

Cipla

TEVA

Medior Healthcare

West-Ward

Shandong Xinshidai Pharmaceutical

HISUN

Shenzhen Wanle Pharmaceutical